Your browser doesn't support javascript.
loading
Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.
Chan, David L; Hayes, Aimee R; Karfis, Ioannis; Conner, Alice; Furtado O'Mahony, Luke; Mileva, Magdalena; Bernard, Elizabeth; Roach, Paul; Marin, Gwennaëlle; Pavlakis, Nick; Schembri, Geoffrey; Gnanasegaran, Gopinath; Marin, Clementine; Vanderlinden, Bruno; Navalkissoor, Shaunak; Caplin, Martyn E; Flamen, Patrick; Toumpanakis, Christos; Bailey, Dale L.
Afiliación
  • Chan DL; Medical Oncology, ENETS Centre of Excellence, Royal North Shore Hospital, Sydney, NSW, Australia. david.chan@sydney.edu.au.
  • Hayes AR; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. david.chan@sydney.edu.au.
  • Karfis I; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK.
  • Conner A; Nuclear Medicine, Institut Jules Bordet-Université Libre de Bruxelles, Brussels, Belgium.
  • Furtado O'Mahony L; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Mileva M; University College London Medical School, University College London, London, UK.
  • Bernard E; Nuclear Medicine, Institut Jules Bordet-Université Libre de Bruxelles, Brussels, Belgium.
  • Roach P; Nuclear Medicine, ENETS Centre of Excellence, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Marin G; Nuclear Medicine, ENETS Centre of Excellence, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Pavlakis N; Nuclear Medicine, Institut Jules Bordet-Université Libre de Bruxelles, Brussels, Belgium.
  • Schembri G; Medical Oncology, ENETS Centre of Excellence, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Gnanasegaran G; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Marin C; Nuclear Medicine, ENETS Centre of Excellence, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Vanderlinden B; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK.
  • Navalkissoor S; Nuclear Medicine, Royal Free Hospital, London, UK.
  • Caplin ME; Nuclear Medicine, Institut Jules Bordet-Université Libre de Bruxelles, Brussels, Belgium.
  • Flamen P; Medical Physics, Institut Jules Bordet-Université Libre de Bruxelles, Brussels, Belgium.
  • Toumpanakis C; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK.
  • Bailey DL; Nuclear Medicine, Royal Free Hospital, London, UK.
Br J Cancer ; 128(4): 549-555, 2023 02.
Article en En | MEDLINE | ID: mdl-36434154
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Tumores Neuroendocrinos / Neoplasias Gastrointestinales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Tumores Neuroendocrinos / Neoplasias Gastrointestinales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Australia